The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
Open accessAbstract
There is compelling rationale for manipulating the microbiota to treat inflammatory bowel diseases (IBDs). Although studies of animal models of intestinal inflammation produced promising results, trials in humans have been disappointing. In contrast to IBD, the role of the microbiota in the development of irritable bowel syndrome (IBS) only recently has been considered, but early stage results have been encouraging. As pharmaceutical companies develop fewer truly novel agents for treatment of these disorders, consumers seek safer, long-term strategies to deal with chronic symptoms. We assess the rationale for modulating the microbiota for treatment of IBD and IBS, and discuss whether current concepts are simplistic and overstated or simply under-researched. Are claims exaggerated and expectations unrealistic? Difficulties with microbiota terminology and technologies, as well as differences among patients and the heterogeneity of these diseases, pose additional challenges in developing microbiota-based therapies for IBD and IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some instances, changed microbiota may be an appropriate response to a change in the host, or may represent an epiphenomenon without pathophysiological implications [22] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [22]
In the citing paper
“Despite the therapeutic potential of FMT for the treatment of PD, several limitations still exist and need to be addressed. Standard clinical protocols, delivery methods, periodicity, donor’s selection criteria, patient’s inclusion criteria, long-term benefits and potential risks remain an issue [463,467,481,482,483,484,485].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [483]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Consumption of fermented milk product with probiotic modulates brain activity
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
O'Mahony, S. M., Marchesi, J. R., Scully, P., Codling, C., Ceolho, A.-M., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.026 · Cited by 1,069
Self-citationRifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
The microbiome-gut-brain axis: from bowel to behavior
Cryan, J. F., & O’Mahony, S. M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01664.x · Cited by 990
Bacteria, Colonic Fermentation, and Gastrointestinal Health
Macfarlane, G. T., & Macfarlane, S. (2012) · Journal of AOAC INTERNATIONAL · doi:10.5740/jaoacint.sge_macfarlane · Cited by 970
Cadwell, K., Patel, K., Maloney, N. S., Liu, T., Ng, A., Storer, C. E., Head, R. D., Xavier, R. J., Stappenbeck, T. S., & Virgin, H. W. (2010) · Cell · doi:10.1016/j.cell.2010.05.009 · Cited by 927
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835
Self-citationEradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728
Self-citationIntestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis
Kuss-Duerkop, S. K., Best, G. T., Etheredge, C. A., Pruijssers, A. J. P., Frierson, J. M., Hooper, L. V., Dermody, T. S., & Pfeiffer, J. K. (2011) · Science · doi:10.1126/science.1211057 · Cited by 631
Collins, S. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70034-3 · Cited by 511
Preidis, G. A., & Versalovic, J. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.072 · Cited by 494
Antibiotic use and inflammatory bowel diseases in childhood
Hviid, A. P., Svanström, H., & Frisch, M. (2010) · Gut · doi:10.1136/gut.2010.219683 · Cited by 492
Shaw, S. Y., Blanchard, J., & Bernstein, C. N. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.398 · Cited by 484
Thomas, C. M., & Versalovic, J. A. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.11712 · Cited by 470
Kim, H. J., Camilleri, M., Mckinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M., & Zinsmeister, A. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01543.x · Cited by 468
Whitehead, W. E., Engel, B. T., & Schuster, M. M. (1980) · Digestive Diseases and Sciences · doi:10.1007/bf01395503 · Cited by 462
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2013) · Gut Microbes · doi:10.4161/gmic.25487 · Cited by 448 · cited 1×
“There have been a few reports of the ability of orally administered probiotics to accelerate(47) or slow(48,49) colonic transit, influence brain activation,(50) and alter circulating cytokines.(51) Other opportunities for intervention also may be available.”
BackgroundSelf-citationKim, H. J., Vazquez Roque, M. I., Camilleri, M., Stephens, D., Burton, D. D., Baxter, K., Thomforde, G., & Zinsmeister, A. R. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00695.x · Cited by 400
Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses
Hand, T. W., dos Santos, L. M., Bouladoux, N. J., Molloy, M. J., Pagán, A. J., Pepper, M., Maynard, C. L., Elson, C. O., & Belkaid, Y. (2012) · Science · doi:10.1126/science.1220961 · Cited by 387
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
McFarland, L. V., & Dublin, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2650 · Cited by 341
AGRAWAL, A., HOUGHTON, L. A., MORRIS, J., REILLY, B., GUYONNET, D., GOUPIL FEUILLERAT, N., SCHLUMBERGER, A., JAKOB, S., & WHORWELL, P. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03853.x · Cited by 334
Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease
Barbara, G., Stanghellini, V., Brandi, G., Cremon, C., Nardo, G. D., De Giorgio, R., & Corinaldesi, R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00230.x · Cited by 325
Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease
Anderson, J. E., Edney, R. J., & Whelan, K. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05220.x · Cited by 313
Carroll, I. M., Ringel-Kulka, T., Keku, T. O., Chang, Y.-H., Packey, C. D., Sartor, R. B., & Ringel, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2011 · Cited by 292
An overview of fecal microbiota transplantation: techniques, indications, and outcomes
Brandt, L. J., & Aroniadis, O. C. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.03.1329 · Cited by 268
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256
Probiotics for maintenance of remission in Crohn's disease
Rolfe, V. E., Fortun, P., Hawkey, C. J., & Bath-Hextall, F. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004826.pub2 · Cited by 252
Damman, C. J., Miller, S. I., Surawicz, C. M., & Zisman, T. L. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.93 · Cited by 229
Metagenomics and Personalized Medicine
Virgin, H. W., & Todd, J. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.009 · Cited by 205
Interventions for prevention of post-operative recurrence of Crohn's disease
Doherty, G. A., Bennett, G., Patil, S. A., Cheifetz, A. S., & Moss, A. C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006873.pub2 · Cited by 202
Helicobacter pylori infection in functional dyspepsia
Suzuki, H., & Moayyedi, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.9 · Cited by 196
Probiotics for maintenance of remission in ulcerative colitis
Iheozor‐Ejiofor, Z., Kaur, L., Gordon, M. A., Baines, P. A., Sinopoulou, V., & Akobeng, A. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007443.pub3 · Cited by 193
Spiller, R. E., & Lam, C. (2012) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2012.18.3.258 · Cited by 179
Rahimi, R., Nikfar, S., Rahimi, F. C., Elahi, B., Derakhshani, S., Vafaie, M., & Abdollahi, M. R. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0171-0 · Cited by 173
Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials
Nikfar, S., Rahimi, R., Rahimi, F., Derakhshani, S., & Abdollahi, M. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9335-z · Cited by 155
Quigley, E. M. M., & Flourie, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00879.x · Cited by 151
Self-citationProbiotics for maintenance of remission in ulcerative colitis
Naidoo, K., Gordon, M. A., Fagbemi, A. O., Thomas, A. G., & Akobeng, A. K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007443.pub2 · Cited by 136
Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
Sang, L.-X. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i15.1908 · Cited by 133
Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
Manichanh, C., Eck, A., Varela, E., Roca, J., Clemente, J. C., González, A., Knights, D., Knight, R. D., Estrella, S., Hernandez, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303013 · Cited by 127
The microbiota link to irritable bowel syndrome
Jeffery, I. B., Quigley, E. M. M., Öhman, L., Simrén, M., & O’Toole, P. W. (2012) · Gut Microbes · doi:10.4161/gmic.21772 · Cited by 114
Self-citationShanahan, F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.025 · Cited by 107
Self-citationThe colonic microbiota in health and disease
Shanahan, F. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a3493 · Cited by 104
Self-citationGut motor function: immunological control in enteric infection and inflammation
Khan, W. I., & Collins, S. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02979.x · Cited by 103
The gut microbiota—a clinical perspective on lessons learned
Shanahan, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.145 · Cited by 100
Self-citationBacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts
van Tol, E. A. F., Holt, L. C., Li, F. L., Kong, F., Rippe, R. A., Yamauchi, M., Pucilowska, J. B., Lund, P. K., & Sartor, R. B. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.1.g245 · Cited by 100
Mourelle, M., Salas, A., Guarner, F., Crespo, E., Garcia-Lafuente, A. M., & Malagelada, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70535-9 · Cited by 98
Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease
Doherty, G. A., Bennett, G., Cheifetz, A. S., & Moss, A. C. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04231.x · Cited by 84
Use of broad-spectrum antibiotics and the development of irritable bowel syndrome.
Villarreal, A. A., Aberger, F. J., Benrud, R., & Gundrum, J. D. (2012) · PubMed · Cited by 78
Andriulli, A., Neri, M., Loguercio, C., Terreni, N., Merla, A., Cardarella, M. P., Federico, A., Chilovi, F., Milandri, G. L., De Bona, M., et al. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817fadd6 · Cited by 75
A Commentary on the Safety of Probiotics
Shanahan, F. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.006 · Cited by 73
Self-citationBacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management
Quigley, E. M. M. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00277.x · Cited by 67
Self-citationQuigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67 · cited 1×
“Clinicians will appreciate the clinical benefits produced by interventions that are likely to modify the intestinal microbiota in patients with IBS and related disorders; these interventions include antibiotics, prebiotics, and probiotics.(40) Antibiotics such as rifaximin have been shown to produce consistent, albeit…”
BackgroundSelf-citationProbiotics for maintenance of remission in ulcerative colitis
Naidoo, K., Gordon, M. A., Fagbemi, A. A., Thomas, A. G., & Akobeng, A. K. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2010.186338.123 · Cited by 65
Shen, J., Ran, H. Z., Yin, M. H., Zhou, T., & Xiao, D. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01791.x · Cited by 59
Gut Microbes: From Bugs to Drugs
Shanahan, F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.729 · Cited by 57
Self-citationRigby, R. J., Hunt, M. R., Scull, B., Simmons, J. G., Speck, K. E., Helmrath, M. A., & Lund, P. K. (2009) · Gut · doi:10.1136/gut.2008.157636 · Cited by 47
The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain
Shanahan, F. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00502.x · Cited by 43
Self-citationShanahan, F., Dinan, T. G., Ross, R. P., & Hill, C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.09.020 · Cited by 35
Self-citationBugs on the brain; brain in the gut—seeking explanations for common gastrointestinal symptoms
Quigley, E. M. M. (2012) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-012-0865-y · Cited by 25
Self-citationProbiotics in Gastrointestinal Disorders
Quigley, E. M. M. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.349 · Cited by 23
Self-citationBothin, C., & Midtvedt, T. (2008) · European Surgical Research · doi:10.1159/000129221 · Cited by 12
Bird, L. (2015) · Nature reviews. Immunology · doi:10.1038/nri3882 · Cited by 10
25 Early-Life Dysbiosis Leads to Visceral Hypersensitivity in Adulthood
O’Mahony, S. M., Savignac, H. M., O’Brien, T., Scully, P., Quigley, E. M. M., Marchesi, J. R., O’Toole, P. W., Dinan, T. G., & Cryan, J. F. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)60019-4 · Cited by 8
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
“One potential approach is the manipulation of enteric bacteria through probiotics and prebiotics, which have had limited success in humans thus far (Butterworth et al., 2008; Naidoo et al., 2011; Shanahan and Quigley, 2014).”
BackgroundParamsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M. D., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 1,102
Self-citationKynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724
“There is much interest in the minute regarding the possible wider application of faecal microbiota transplant beyond its use for the treatment of Clostridium difficile infection (Kelly et al., 2015a; Shanahan and Quigley, 2014).”
BackgroundGut microbiome and aging: physiological and mechanistic insights
Nagpal, R., Mainali, R., Ahmadi, S., Wang, S., Singh, R., Kavanagh, K., Kitzman, D. W., Kushugulova, A., Marotta, F., & Yadav, H. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-170030 · Cited by 670
Metadata
- Authors
- Shanahan, F., & Quigley, E. M. M.
- Affiliations
- National University of Ireland (IE)
- Houston Methodist (US)
- Corresponding author
- Shanahan, Fergus
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1554-1563
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2172135635
- Cited by
- 172
- References
- 67
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 12 · 2019: 17 · 2018: 13 · 2017: 20 · 2016: 27 · 2015: 22 · 2014: 17
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, microbiota-based therapy, irritable bowel syndrome, inflammatory bowel disease, microbiota modulation, intestinal inflammation, disease heterogeneity
- MeSH terms
- Animals, Biological Therapy, Feces, Humans, Intestines, Inflammatory Bowel Diseases, Treatment Outcome, Probiotics, Irritable Bowel Syndrome, Host-Pathogen Interactions, Prebiotics, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
